Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Fateme Shamekhi Amiri. (2016) Serum tumor markers in chronic kidney disease: as clinical tool in diagnosis, treatment and prognosis of cancers. Renal Failure 38:4, pages 530-544.
Read now
Read now
Kenneth Højsgaard Jensen, Linda Hilsted, Claus Jensen, Tommie Mynster, Jens F. Rehfeld & Ulrich Knigge. (2013) Chromogranin A is a sensitive marker of progression or regression in ileo-cecal neuroendocrine tumors. Scandinavian Journal of Gastroenterology 48:1, pages 70-77.
Read now
Read now
Articles from other publishers (36)
Hui Yu, Hongping Wang, Xue Su, Aili Cao, Xingmei Yao, Yunman Wang, Bingbing Zhu, Hao Wang & Ji Fang. (2022) Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy. BMC Nephrology 23:1.
Crossref
Crossref
Melina Ioannidis, Sushil K. Mahata & Geert van den Bogaart. (2022) The immunomodulatory functions of chromogranin A-derived peptide pancreastatin. Peptides 158, pages 170893.
Crossref
Crossref
Lovorka Grgurevic, Rudjer Novak, Grgur Salai, Stela Hrkac, Marko Mocibob, Ivana Kovacevic Vojtusek & Mario Laganovic. (2022) Stage II of Chronic Kidney Disease—A Tipping Point in Disease Progression?. Biomedicines 10:7, pages 1522.
Crossref
Crossref
Jasmijn A van Balveren, Lale Erdem-Eraslan, Wilhelmine P.H.G. Verboeket-van de Venne, Carine J.M. Doggen, Johannes Hofland, Wytze P. Oosterhuis, Yolanda B. de Rijke, Rein M.J. Hoedemakers & Ron Kusters. (2022) Awareness of drug laboratory test interactions is important for prevention of unnecessary additional diagnostics: An example. Clinica Chimica Acta 530, pages 99-103.
Crossref
Crossref
Mirko Luketin, Maja Mizdrak, Dijana Boric-Skaro, Dinko Martinovic, Daria Tokic, Marino Vilovic, Daniela Supe-Domic, Tina Ticinovic Kurir & Josko Bozic. (2021) Plasma Catestatin Levels and Advanced Glycation End Products in Patients on Hemodialysis. Biomolecules 11:3, pages 456.
Crossref
Crossref
Jonas Baekdal, Jesper Krogh, Marianne Klose, Pernille Holmager, Seppo W. Langer, Peter Oturai, Andreas Kjaer, Birgitte Federspiel, Linda Hilsted, Jens F. Rehfeld, Ulrich Knigge & Mikkel Andreassen. (2020) Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors. Diagnostics 10:11, pages 881.
Crossref
Crossref
Saiful A. Mir, Nilima Biswas, Wai Cheung, Ji Wan, Nicholas Webster, Etienne Macedo, Daniel T. O’Connor & Sucheta M. Vaingankar. (2020) Chromogranin A pathway: from pathogenic molecule to renal disease. Journal of Hypertension 38:3, pages 456-466.
Crossref
Crossref
Karin Gmitterova, Daniela Varges, Matthias Schmitz, Saima Zafar, Fabian Maass, Paul Lingor & Inga Zerr. (2020) Chromogranin A Analysis in the Differential Diagnosis Across Lewy Body Disorders. Journal of Alzheimer's Disease 73:4, pages 1355-1361.
Crossref
Crossref
Miroslav Sekulic, Sushrut Waikar, Shveta S. Motwani, Astrid Weins & Helmut G. Rennke. (2019) Chromogranin A Tubulopathy: Differing Histopathologic Patterns of Acute Tubular Injury in the Setting of Neuroendocrine Neoplasms. Kidney International Reports 4:8, pages 1085-1093.
Crossref
Crossref
Alexander V. Fisher, Alexandra G. Lopez-Aguiar, Victoria R. Rendell, Courtney Pokrzywa, Flavio G. Rocha, Zaheer S. Kanji, George A. Poultsides, Eleftherios A. Makris, Mary E. Dillhoff, Eliza W. Beal, Ryan C. Fields, Roheena Z. Panni, Kamran Idrees, Paula Marincola Smith, Clifford S. Cho, Megan V. Beems, Shishir K. Maithel, Emily R. Winslow, Daniel E. Abbott & Sharon M. Weber. (2019) Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors. Journal of Gastrointestinal Surgery 23:4, pages 651-658.
Crossref
Crossref
Michael JW Thompson, Venkat Parameswaran & John R Burgess. (2018) Clinical utility of chromogranin A for the surveillance of succinate dehydrogenase B- and succinate dehydrogenase D-related paraganglioma. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 56:1, pages 163-169.
Crossref
Crossref
Gustav Mikkelsen, Arne Åsberg, Maria E. Hultström, Knut Aasarød & Gunhild G. Hov. (2017) Reference Limits for Chromogranin A, CYFRA 21-1, CA 125, CA 19-9 and Carcinoembryonic Antigen in Patients with Chronic Kidney Disease. The International Journal of Biological Markers 32:4, pages 461-466.
Crossref
Crossref
Jonathan Wong, Raja Mohammed Kaja Kamal, Enric Vilar & Ken Farrington. (2016) Measuring Residual Renal Function in Hemodialysis Patients without Urine Collection. Seminars in Dialysis 30:1, pages 39-49.
Crossref
Crossref
Nitish R. Mahapatra, Sajalendu Ghosh, Manjula Mahata, Gautam K. Bandyopadhyay & Sushil K. Mahata. 2017. Chromogranins: from Cell Biology to Physiology and Biomedicine. Chromogranins: from Cell Biology to Physiology and Biomedicine
195
211
.
Kasper Broedbaek & Linda Hilsted. (2016) Chromogranin A as biomarker in diabetes. Biomarkers in Medicine 10:11, pages 1181-1189.
Crossref
Crossref
Joanne E Adaway, Rebecca Dobson, Jennifer Walsh, Daniel J Cuthbertson, Phillip J Monaghan, Peter J Trainer, Juan W Valle & Brian G Keevil. (2016) Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 53:5, pages 554-560.
Crossref
Crossref
Christian A. Koch, Christina Pamporaki & Vitaly Kantorovich. 2015. Chronic Kidney Disease and Hypertension. Chronic Kidney Disease and Hypertension
185
231
.
Lawrence B. Afrin. (2014) Mast Cell Activation Syndrome as a Significant Comorbidity in Sickle Cell Disease. The American Journal of the Medical Sciences 348:6, pages 460-464.
Crossref
Crossref
Samuel Zuber, Robert Wesley, Tamara Prodanov, Graeme Eisenhofer, Karel Pacak & Vitaly Kantorovich. (2014)
Clinical utility of chromogranin A in
SDHx-
related paragangliomas
. European Journal of Clinical Investigation 44:4, pages 365-371.
Crossref
Crossref
Jens P GoetzeUrban Alehagen, Allan Flyvbjerg & Jens F Rehfeld. (2014) Chromogranin A as a biomarker in cardiovascular disease. Biomarkers in Medicine 8:1, pages 133-140.
Crossref
Crossref
PR Bech, NM Martin, R Ramachandran & SR Bloom. (2013) The biochemical utility of chromogranin A, chromogranin B and cocaine- and amphetamine-regulated transcript for neuroendocrine neoplasia. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 51:1, pages 8-21.
Crossref
Crossref
Giuseppe Coppolino, Davide Bolignano, Laura Rivoli, Giuseppe Mazza, Piera Presta & Giorgio Fuiano. (2014) Tumour Markers and Kidney Function: A Systematic Review. BioMed Research International 2014, pages 1-9.
Crossref
Crossref
Carlo Donadio, Danika Tognotti & Elena Donadio. (2012) Albumin modification and fragmentation in renal disease. Clinica Chimica Acta 413:3-4, pages 391-395.
Crossref
Crossref
C M Korse, M Muller & B G Taal. (2011) Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours. British Journal of Cancer 105:8, pages 1173-1175.
Crossref
Crossref
Nicolette van Duinen, Ido P. Kema, Johannes A. Romijn & Eleonora P.M. Corssmit. (2011) Plasma chromogranin A levels are increased in a small portion of patients with hereditary head and neck paragangliomas. Clinical Endocrinology 74:2, pages 160-165.
Crossref
Crossref
Giovanna Castoldi, Laura Antolini, Camila Bombardi, Lucia Perego, Paola Mariani, Maria Rosa Viganò, Giacomo Torti, Marco Casati, Angelo Corti, Gianpaolo Zerbini, Maria Grazia Valsecchi & Andrea Stella. (2010) Oxidative stress biomarkers and chromogranin A in uremic patients: Effects of dialytic treatment. Clinical Biochemistry 43:18, pages 1387-1392.
Crossref
Crossref
M. d’Herbomez, C. Do Cao, D. Vezzosi, F. Borzon-Chasot & E. Baudin. (2010) Chromogranin A assay in clinical practice. Annales d'Endocrinologie 71:4, pages 274-280.
Crossref
Crossref
Helge Røsjø, Serge Masson, Roberto Latini, Allan Flyvbjerg, Valentina Milani, Maria Teresa La Rovere, Miriam Revera, Alessandro Mezzani, Gianni Tognoni, Luigi Tavazzi & Torbjørn Omland. (2010) Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial. European Journal of Heart Failure 12:6, pages 549-556.
Crossref
Crossref
Dan Zhang, Thomas Lavaux, Anne-Claire Voegeli, Thierry Lavigne, Vincent Castelain, Nicolas Meyer, Rémy Sapin, Dominique Aunis, Marie-Hélène Metz-Boutigue & Francis Schneider. (2008) Prognostic Value of Chromogranin A at Admission in Critically Ill Patients: A Cohort Study in a Medical Intensive Care Unit. Clinical Chemistry 54:9, pages 1497-1503.
Crossref
Crossref
A. M. Jansson, H. Rosjo, T. Omland, T. Karlsson, M. Hartford, A. Flyvbjerg & K. Caidahl. (2008) Prognostic value of circulating chromogranin A levels in acute coronary syndromes. European Heart Journal 30:1, pages 25-32.
Crossref
Crossref
Rany M. Salem, Peter E. Cadman, Yuqing Chen, Fangwen Rao, Gen Wen, Bruce A. Hamilton, Brinda K. Rana, Douglas W. Smith, Mats Stridsberg, Harry J. Ward, Manjula Mahata, Sushil K. Mahata, Donald W. Bowden, Pamela J. Hicks, Barry I. Freedman, Nicholas J. Schork & Daniel T. O'Connor. (2008) Chromogranin A Polymorphisms Are Associated With Hypertensive Renal Disease. Journal of the American Society of Nephrology 19:3, pages 600-614.
Crossref
Crossref
Ilona Kurnatowska & Michał Nowicki. (2006) Serum chromogranin A concentration and intradialytic hypotension in chronic haemodialysis patients. International Urology and Nephrology 38:3-4, pages 701-705.
Crossref
Crossref
Mette Elise Estensen, Aina Hognestad, Unni Syversen, Iain Squire, Leong Ng, John Kjekshus, Kenneth Dickstein & Torbjørn Omland. (2006) Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction. American Heart Journal 152:5, pages 927.e1-927.e6.
Crossref
Crossref
Benjamin Nisman, Norman Heching, Haim Biran, Vivian Barak & Tamar Peretz. (2006) The Prognostic Significance of Circulating Neuroendocrine Markers Chromogranin A, Pro-Gastrin-Releasing Peptide and Neuron-Specific Enolase in Patients with Advanced Non-Small-Cell Lung Cancer. Tumor Biology 27:1, pages 8-16.
Crossref
Crossref
Graeme Eisenhofer, Frans Huysmans, Karel Pacak, Macclellan M. Walther, Fred C.G.J. Sweep & Jacques W.M. Lenders. (2005) Plasma metanephrines in renal failure. Kidney International 67:2, pages 668-677.
Crossref
Crossref
Aldo Spadaro. (2005) Serum chromogranin-A in hepatocellular carcinoma: Diagnostic utility and limits. World Journal of Gastroenterology 11:13, pages 1987.
Crossref
Crossref